ReviewDrugs2013
Natalizumab: a review of its use in the management of relapsing-remitting multiple sclerosis.
Paul L McCormackPubMed ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this paperpooled ittrialcites it
ReviewDrugs2013
Paul L McCormackPubMed ↗Publisher ↗
No numbers read from the abstract.